Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1981 10
1982 2
1983 3
1984 3
1985 4
1986 4
1987 12
1988 24
1989 30
1990 24
1991 29
1992 33
1993 34
1994 26
1995 25
1996 29
1997 40
1998 33
1999 23
2000 15
2001 17
2002 18
2003 21
2004 15
2005 11
2006 13
2007 12
2008 20
2009 18
2010 16
2011 16
2012 17
2013 19
2014 23
2015 19
2016 23
2017 19
2018 26
2019 19
2020 23
2021 28
Text availability
Article attribute
Article type
Publication date

Search Results

769 results
Results by year
Filters applied: . Clear all
Page 1
Azelastine.
[No authors listed] [No authors listed] 2021 Sep 20. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. 2021 Sep 20. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. PMID: 30000120 Free Books & Documents. Review.
Small occasional doses of azelastine nasal spray would not be expected to cause any adverse effects in breastfed infants. ...The oral, nonsedating antihistamines are preferred alternatives. Because absorption from the eye is limited, azelastine would not be expected …
Small occasional doses of azelastine nasal spray would not be expected to cause any adverse effects in breastfed infants. ...The oral …
For the Patient.
[No authors listed] [No authors listed] Allergy Asthma Proc. 2020 Jul 1;41(4):309. doi: 10.2500/aap.2020.41.200049. Allergy Asthma Proc. 2020. PMID: 32605703 No abstract available.
Anti-allergic drug azelastine suppresses colon tumorigenesis by directly targeting ARF1 to inhibit IQGAP1-ERK-Drp1-mediated mitochondrial fission.
Hu HF, Xu WW, Li YJ, He Y, Zhang WX, Liao L, Zhang QH, Han L, Yin XF, Zhao XX, Pan YL, Li B, He QY. Hu HF, et al. Theranostics. 2021 Jan 1;11(4):1828-1844. doi: 10.7150/thno.48698. eCollection 2021. Theranostics. 2021. PMID: 33408784 Free PMC article.
The target protein of azelastine was analyzed and confirmed by DARTS, WST-1, Biacore and tumor xenograft assays. ...ARF1 was identified as a direct target of azelastine. High ARF1 expression was associated with advanced stages and poor survival of CRC. ...
The target protein of azelastine was analyzed and confirmed by DARTS, WST-1, Biacore and tumor xenograft assays. ...ARF1 was identifi …
Azelastine nasal spray: a review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis.
Lieberman PL, Settipane RA. Lieberman PL, et al. Allergy Asthma Proc. 2003 Mar-Apr;24(2):95-105. Allergy Asthma Proc. 2003. PMID: 12776442 Review.
Azelastine hydrochloride is a pharmacologically distinct H1-receptor antagonist with a broad spectrum of antiallergic and anti-inflammatory activity. ...This article reviews the pharmacologic profile and clinical efficacy and safety of azelastine nasal spray....
Azelastine hydrochloride is a pharmacologically distinct H1-receptor antagonist with a broad spectrum of antiallergic and anti-inflam
Vasomotor rhinitis.
Pattanaik D, Lieberman P. Pattanaik D, et al. Curr Allergy Asthma Rep. 2010 Mar;10(2):84-91. doi: 10.1007/s11882-010-0089-z. Curr Allergy Asthma Rep. 2010. PMID: 20425499 Review.
Therapy should be based on the presenting symptoms of vasomotor rhinitis. Combination therapy with topical corticosteroids and azelastine is useful. However, in patients whose predominant symptom is rhinorrhea, use of atopical anticholinergic agents can be quite useful. .. …
Therapy should be based on the presenting symptoms of vasomotor rhinitis. Combination therapy with topical corticosteroids and azelastine
Treatment of nonallergic perennial rhinitis.
Ciprandi G. Ciprandi G. Allergy. 2004;59 Suppl 76:16-22; discussion 22-3. doi: 10.1111/j.0108-1675.2004.00390.x. Allergy. 2004. PMID: 14984552 Review.
While clinical studies of azelastine have demonstrated that this drug is highly efficacious in the treatment of all the symptoms of vasomotor rhinitis, mechanistic studies have demonstrated that azelastine has potent anti-inflammatory effects (in particular attenuat …
While clinical studies of azelastine have demonstrated that this drug is highly efficacious in the treatment of all the symptoms of v …
Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
Bernstein JA. Bernstein JA. Curr Med Res Opin. 2007 Oct;23(10):2441-52. doi: 10.1185/030079907X226302. Curr Med Res Opin. 2007. PMID: 17723160 Review.
Azelastine has demonstrated a wide range of pharmacologic effects on chemical mediators of inflammation including leukotrienes, kinins, and platelet activating factor in vitro and in vivo. ...Clinical studies demonstrated that azelastine nasal spray can improve symp
Azelastine has demonstrated a wide range of pharmacologic effects on chemical mediators of inflammation including leukotrienes, kinin
A novel and effective approach to treating rhinitis with nasal antihistamines.
Kaliner MA. Kaliner MA. Ann Allergy Asthma Immunol. 2007 Nov;99(5):383-90; quiz 391-2, 418. doi: 10.1016/S1081-1206(10)60560-1. Ann Allergy Asthma Immunol. 2007. PMID: 18051206 Review.
OBJECTIVES: To review existing treatments for rhinitis and summarize data available on the use of a nasal antihistamine (azelastine) in treating allergic and nonallergic vasomotor rhinitis. ...In all trials, azelastine was associated with a rapid onset of action and …
OBJECTIVES: To review existing treatments for rhinitis and summarize data available on the use of a nasal antihistamine (azelastine) …
Azelastine enhances the clinical efficacy of glucocorticoid by modulating MKP-1 expression in allergic rhinitis.
Luo X, Ma R, Wu X, Xian D, Li J, Mou Z, Li H. Luo X, et al. Eur Arch Otorhinolaryngol. 2015 May;272(5):1165-73. doi: 10.1007/s00405-014-3191-3. Epub 2014 Jul 25. Eur Arch Otorhinolaryngol. 2015. PMID: 25060977
Azelastine was suggested as a supplementary choice of glucocorticoid for the control of moderate to severe allergic rhinitis (AR). ...Azelastine and budesonide additively increased MKP-1 expression and inhibited ICAM-1 expression in vitro. ...
Azelastine was suggested as a supplementary choice of glucocorticoid for the control of moderate to severe allergic rhinitis (AR). ..
769 results